SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): April 16, 2003
NEOGENOMICS, INC.
(f/k/a American Communications Enterprises, Inc.)
(Exact Name of Registrant as Specified in Charter)
| Nevada | 333-72097 | 74-2897368 | ||
|
|
||||
| (State or Other Jurisdiction | (Commission File Number) | (IRS Employer | ||
| of Incorporation) | Identification Number) |
| 1726 Medical Boulevard, Suite 201, Naples Florida | 34108 | |
|
|
||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (941) 923-1949
1
Item 5. Other Events.
On April 16, 2003, the Registrant closed certain transactions entered into with Medical Venture Partners, LLC, a Naples, Florida based venture capital group (“MVP”), and its principals. A press release, dated April 15, 2003, announcing the agreements with MVP, among other items, is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 7. Exhibits
99.1 Press Release issued by the Registrant on April 15, 2003.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: April 16, 2003 | ||||
| NEOGENOMICS, INC. | ||||
| By: | /s/ Michael T. Dent, M.D. Michael T. Dent, M.D., President and Chief Executive Officer |
3